Research Paper Volume 14, Issue 23 pp 9715—9729
A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy
Figure 5. Time-dependent receiver operating characteristic curves (ROC) and area under the curve (AUC) for OS prediction. (A) Time-dependent ROC and AUC for the entire dataset; (B) Time-dependent ROC and AUC for AJCC pathology stage II; (C) Time-dependent ROC and AUC for AJCC pathology stage III; (D) Time-dependent ROC and AUC for AJCC pathology stage IV; (E) Time-dependent ROC and AUC for females; (F) Time-dependent ROC and AUC for males; (G) Time-dependent ROC and AUC for age ≥ 65; (H) Time-dependent ROC and AUC for age <65.